Host Response to Pessaries in Microbial Communities of the Postmenopausal Vagina
Status: | Completed |
---|---|
Conditions: | Urology, Urology |
Therapuetic Areas: | Nephrology / Urology |
Healthy: | No |
Age Range: | 51 - Any |
Updated: | 1/23/2019 |
Start Date: | April 2016 |
End Date: | June 2018 |
Host Response to Pessaries in Microbial Communities of the Postmenopausal
The ability to determine the postmenopausal vaginal environment and the impact of pessary use
could help to maximize pessary therapy and non-surgical treatment for such a prevalent
problem.
could help to maximize pessary therapy and non-surgical treatment for such a prevalent
problem.
The study will advance the care of elderly patients through providing data to maximize
non-surgical options to those at high risk for having surgery and its attending morbidity. In
characterizing substantive differences in the vaginal environment of successful and
unsuccessful pessary users, the investigators can identify elderly patients at higher risk of
adverse events with pessary use as well as novel targets for the pharmacologic treatment of
the altered vaginal microbiota and endogenous AMP levels, potentially allowing patients to
continue with non-surgical therapies rather than pursuing surgical intervention.
non-surgical options to those at high risk for having surgery and its attending morbidity. In
characterizing substantive differences in the vaginal environment of successful and
unsuccessful pessary users, the investigators can identify elderly patients at higher risk of
adverse events with pessary use as well as novel targets for the pharmacologic treatment of
the altered vaginal microbiota and endogenous AMP levels, potentially allowing patients to
continue with non-surgical therapies rather than pursuing surgical intervention.
Inclusion Criteria:
- must be English speaking
- appropriate for pessary treatment
- pelvic floor conditions such as POP (with or without the presence of a uterus), stress
urinary incontinence, urge urinary incontinence, or any combination of the above.
Exclusion Criteria:
- a history of current, symptomatic vaginal stricture
- a history of current, radiation therapy,
- or current treatment with auto-immune suppression agents.
- if they have eroded mesh in the vagina from prior pelvic floor surgery
We found this trial at
1
site
2160 South 1st Avenue
Maywood, Illinois 60153
Maywood, Illinois 60153
(888) 584-7888
Phone: 708-216-2067
Loyola University Medical Center Loyola University Health System is committed to excellence in patient care...
Click here to add this to my saved trials